JAMA

World Health Organization Guidelines for Using GLP-1 Treatments to Manage Obesity in Adults

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗

Updated

Full Text

Full text is available at the source.
View Full Text ↗

Related papers

Oct '20
The Future Directions of Cochrane Neonatal Research
top 30% journal
cited by 19 papers
research support, non-u.s. gov't
Mar '23
The Minderoo-Monaco Report on Plastics and Human Health
top 20% journal
cited by 348 papers
research support, n.i.h., extramural
Nov '22
Folic acid supplements and malaria risk and severity in people using antifolate malaria drugs in affected areas
cited by 28 papers
systematic review
Jun '25
Nutritional guidelines to support GLP-1 treatment for obesity: advice from major health and nutrition organizations
top 5% journal
cited by 48 papers
journal article
May '25
Nutritional guidance to support weight loss treatment with GLP-1 therapy
top 10% journal
cited by 32 papers
journal article
Jun '25
Nutritional Guidelines to Support Weight Loss Treatment with GLP-1 Medications
top 30% journal
cited by 7 papers
journal article
Apr '25
Real-world use, benefits, and side effects of new weight-loss treatments based on GLP-1 receptor activators
top 5% journal
cited by 98 papers
journal article

Featured in

GLP-1 TherapiesGLP-1 TherapiesIssue #14
GLP-1 drugs tied to 18% lower atrial fibrillation risk — and 7.8 point drop in alcohol use disorder scores
↗

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the glp-1 therapies brief

issue #43
Semaglutide linked to 21% lower psychiatric hospitalization risk in bipolar disorder patients
2 days ago7 studies
issue #42
Tirzepatide users lost 14.7% of body weight vs. 10.8% with semaglutide — but Black and Hispanic patients were overrepresented in the lowest-response group
1 week ago8 studies
issue #41
New obesity drug survodutide cut weight by 13% vs 5.4% for placebo in 725 patients
2 weeks ago7 studies
issue #40
GLP-1 users had 3x higher risk of aspiration pneumonia after stroke surgery
3 weeks ago7 studies
issue #39
Semaglutide linked to reduced cigarette craving in 24 smokers
4 weeks ago7 studies
issue #38
Two-thirds of patients kept weight off after stopping GLP-1 drugs
5 weeks ago7 studies
issue #36
Tirzepatide beats semaglutide for weight loss: 8.2% vs 5.8% body weight reduction at 12 months
7 weeks ago7 studies
issue #35
Semaglutide linked to 2.5x higher risk of sudden vision loss
8 weeks ago7 studies
issue #34
Tirzepatide users had 18.4% weight loss vs 11.9% with semaglutide in head-to-head trial
9 weeks ago7 studies
issue #33
Semaglutide linked to 53% lower risk of death in dialysis patients with diabetes
10 weeks ago7 studies
explore the archive
See more issues from the glp-1 therapies brief